This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Al-Lamki, R. S. Articles by Bradley, J. R. Search for Related Content PubMed PubMed Citation Articles by Al-Lamki, R. S. Articles by Bradley, J. R.

(American Journal of Pathology. 2003;163:401-411.)
© 2003 American Society for Investigative Pathology

Expression of Silencer of Death Domains and Death-Receptor-3 in Normal Human Kidney and in Rejecting Renal Transplants

Rafia S. Al-Lamki^*, Jun Wang^*, Sathia Thiru, Nicholas R. Pritchard^*, J. Andrew Bradley, Jordan S. Pober and John R. Bradley^*

From the Departments of Medicine,^* Pathology, and Surgery, University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom; and The Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut

We have previously reported the pattern of cellular expression of tumor necrosis factor receptors (TNFR) in human kidney and their altered expression in transplant rejection. We have extended our studies to examine the expression of Silencer of Death Domains (SODD), a protein that binds to the cytoplasmic portion of TNFR1 to inhibit signaling in the absence of ligand. In normal human kidney SODD is expressed in glomerular endothelial cells where it colocalizes with TNFR1. During acute rejection both SODD and TNFR1 are lost from glomeruli, but we found strong expression of SODD on the luminal surface of tubular epithelial cells. This occurs in the absence of detectable TNFR1 expression, suggesting that SODD could interact with other proteins at these sites. Several other members of the TNF superfamily, including Fas and death receptors (DR)-3, -4, and -5, also contain intracellular death domains, but SODD only interacts with the death domain of DR3. We therefore studied the expression of DR3 in human kidney, and report that this death receptor is up-regulated in renal tubular epithelial cells and endothelial cells of some interlobular arteries, in parallel with SODD, during acute transplant rejection. In less severe rejection episodes, DR3 and SODD were more focally induced, generally at sites of mononuclear cell infiltrates. In ischemic allografts, eg, with acute tubular necrosis but no cellular rejection, DR3 was induced on tubular epithelial cells and on glomerular endothelial cells. These data confirm that TNF receptor family members are expressed in a regulated manner during renal transplant rejection, and identify DR3 as a potential inducible mediator of tubular inflammation and injury.

This article has been cited by other articles:

				B. P. Pappu, A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease J. Exp. Med., May 12, 2008; 205(5): 1049 - 1062. [Abstract] [Full Text] [PDF]

				R. S. Al-Lamki, J. Wang, A. M. Tolkovsky, J. A. Bradley, J. L. Griffin, S. Thiru, E. C.Y. Wang, E. Bolton, W. Min, P. Moore, et al. TL1A Both Promotes and Protects from Renal Inflammation and Injury J. Am. Soc. Nephrol., May 1, 2008; 19(5): 953 - 960. [Abstract] [Full Text] [PDF]

				I. Charles, A. Khalyfa, D. M. Kumar, R. R. Krishnamoorthy, R. S. Roque, N. Cooper, and N. Agarwal Serum Deprivation Induces Apoptotic Cell Death of Transformed Rat Retinal Ganglion Cells via Mitochondrial Signaling Pathways Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1330 - 1338. [Abstract] [Full Text] [PDF]